Pan-European Survey on the Under Treatment of Hypercholesterolemia
Pan-European Survey on the Under Treatment of Hypercholesterolemia
The survey try to establish the proportion of patients on lipid-lowering pharmacological
 treatment reaching the LDL-C goals according to the Third Joint European Task Force
 guidelines, overall and by country.·
Inclusion Criteria:

 -  Patients had to be on a lipid-lowering drug treatment for at least 3 months, with no
 dose change for a minimum of 6 weeks.